Vir Biotechnology, Inc. (VIR) has a market capitalization of $1.61B and trades at $10.05. The 52-week range is 4.155-10.94.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.2, Earnings Per Share (EPS) of $-3.16, annual revenue of $68.56M.
The stock has a beta of 1.66, operates in the Healthcare sector.
